The management of myelomatosis.
D000686:Amyloidosis / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003070:Coformycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009378:Neoplasms, Multiple Primary; D010166:Palliative Care; D015649:Pentostatin
D003070:Coformycin; D015649:Pentostatin; D007372:Interferons